Companies Dominating the Topical Androgen Receptor Inhibitors Market
- Cosmo Pharmaceuticals
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Suzhou Kintor Pharmaceuticals Inc
- Sun Pharmaceutical Industries Limited
- Aranda Pharma Ltd
- Selleck Chemicals
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of topical androgen receptor inhibitors is evaluated at USD 58.45 million.
The topical androgen receptor inhibitors market size was over USD 51.72 million in 2024 and is poised to exceed USD 329.18 million by 2037, growing at over 15.3% CAGR during the forecast period i.e., between 2025-2037. Rising aging population, growing healthcare spending and rising acceptance of cosmetic procedures will drive the market growth.
North America industry is estimated to hold largest revenue share of 34% by 2037, due to rising demand for cosmetic operations in the region.
The major players in the market are Cosmo Pharmaceuticals, Suzhou Kintor Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Aranda Pharma Ltd, Selleck Chemicals, Astellas Pharma, Takeda Pharmaceutical, and Daiichi Sankyo.
